Login
Business
Entertainment
World
Health
Environment
Lifestyle
National
Science
Sports
World
Movies
Web Series
Technology
Cricket
Coronavirus
Auto
Ajab Ghazab
Finance
India
International
Religious
Politics
Home Articles Alok Malik
Glenmark launches ‘Hello Skin’ – India’s first Whatsapp based chatbot to help patients suffering from fungal infections \
5 min read
\
\

Glenmark launches ‘Hello Skin’ – India’s first Whatsapp based chatbot to help patients suffering from fungal infections

 24-May-2022
Mumbai (Maharashtra) [India], May 24 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark), an innovation-led global pharmaceutical company, has developed a digital patient education tool, 'Hello Skin' in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists and Leprologists), to help patients suffering from Dermatophytosis (Ring Worm or Tinea) in India, to adhere to the recommended treatment duration.
24-May-2022 Business
\
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin + Metformin fixed dose combination, at an affordable price for adults with Type 2 Diabetes in India \
5 min read
\
\

Glenmark becomes the first company to launch Remogliflozin + Vildagliptin + Metformin fixed dose combination, at an affordable price for adults with Type 2 Diabetes in India

 26-Oct-2021
Mumbai (Maharashtra) [India], October 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed-dose combination (FDC) of its novel, patent-protected, globally researched Sodium-Glucose Co-Transporter Inhibitor (SGLT2i) - Remogliflozin Etabonate and another widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor) - Vildagliptin, with Metformin (first-line medication for the treatment of type 2 diabetes).
26-Oct-2021 Business
\
Glenmark Pharmaceuticals launches fixed-drug combination for management of type 2 diabetes \
3 min read
\
\

Glenmark Pharmaceuticals launches fixed-drug combination for management of type 2 diabetes

 26-Oct-2021
Mumbai (Maharashtra) [India], October 26 (ANI): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed drug combination for the management of type 2 diabetes.
26-Oct-2021 Health
\
Glenmark Pharmaceuticals launches fixed-drug combination for management of type 2 diabetes \
3 min read
\
\

Glenmark Pharmaceuticals launches fixed-drug combination for management of type 2 diabetes

 26-Oct-2021
Mumbai (Maharashtra) [India], October 26 (ANI): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed drug combination for the management of type 2 diabetes.
26-Oct-2021 Health
\